Alison Morilla

1.5k total citations
26 papers, 838 citations indexed

About

Alison Morilla is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Alison Morilla has authored 26 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 13 papers in Pathology and Forensic Medicine and 13 papers in Immunology. Recurrent topics in Alison Morilla's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Alison Morilla is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Alison Morilla collaborates with scholars based in United Kingdom, Canada and Switzerland. Alison Morilla's co-authors include Estella Matutes, Ricardo Morilla, K Owusu-Ankomah, Daniel Catovsky, Roger A’Hern, Ben K. Seon, E Moreau, Ilaria Del Giudice, Julio Delgado and Monica Else and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Alison Morilla

26 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Morilla United Kingdom 13 653 587 377 173 169 26 838
Alice Lynn United States 5 932 1.4× 674 1.1× 390 1.0× 115 0.7× 281 1.7× 8 990
J. Ellis United Kingdom 10 830 1.3× 650 1.1× 502 1.3× 248 1.4× 106 0.6× 14 1.0k
Alice Mohr United States 7 413 0.6× 402 0.7× 139 0.4× 187 1.1× 195 1.2× 14 627
Sharron Glide United Kingdom 4 522 0.8× 417 0.7× 259 0.7× 116 0.7× 53 0.3× 5 578
Silvia Zibellini Italy 13 629 1.0× 459 0.8× 242 0.6× 129 0.7× 223 1.3× 29 761
Emanuele Cencini Italy 13 262 0.4× 281 0.5× 218 0.6× 164 0.9× 103 0.6× 55 535
Lucile Baseggio France 15 473 0.7× 591 1.0× 164 0.4× 249 1.4× 60 0.4× 50 766
Fiona Bennett United Kingdom 8 511 0.8× 391 0.7× 316 0.8× 74 0.4× 84 0.5× 12 585
Maurice Navarro France 6 357 0.5× 320 0.5× 187 0.5× 67 0.4× 94 0.6× 13 500
Michael Pearson United States 4 536 0.8× 518 0.9× 361 1.0× 204 1.2× 90 0.5× 8 860

Countries citing papers authored by Alison Morilla

Since Specialization
Citations

This map shows the geographic impact of Alison Morilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Morilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Morilla more than expected).

Fields of papers citing papers by Alison Morilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Morilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Morilla. The network helps show where Alison Morilla may publish in the future.

Co-authorship network of co-authors of Alison Morilla

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Morilla. A scholar is included among the top collaborators of Alison Morilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Morilla. Alison Morilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morilla, Ricardo, Laphalle Fuller, Nathalie A. Johnson, et al.. (2017). The use of unfixed bone marrow trephines for multicolour flow cytometry. Methods. 134-135. 80–86. 1 indexed citations
2.
Mehra, Niven, George Seed, Maryou Lambros, et al.. (2016). Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS). Annals of Oncology. 27. vi257–vi257. 6 indexed citations
3.
Mehra, Niven, Ricardo Morilla, Adam Sharp, et al.. (2016). High neutrophil-to-lymphocyte ratio (NLR), myeloid-derived suppressor cells (MDSCs) and resistance to corticosteroid therapy (CST) in castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 34(15_suppl). 5076–5076. 3 indexed citations
4.
Anthias, Chloe, Fiona L. Dignan, Ricardo Morilla, et al.. (2014). Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML. Bone Marrow Transplantation. 49(5). 679–683. 58 indexed citations
5.
Hockley, Sarah L., Monica Else, Alison Morilla, et al.. (2012). The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma. British Journal of Haematology. 158(3). 347–354. 44 indexed citations
6.
Oscier, David, Rachel Wade, Zadie Davis, et al.. (2010). Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. Haematologica. 95(10). 1705–1712. 81 indexed citations
7.
Martín, Paloma, Ayoma D. Attygalle, John Swansbury, et al.. (2010). p53 protein overexpression in bone marrow biopsies from chronic lymphocytic leukaemia is associated with TP53 deletion and resistance to fludarabine. Journal of Hematopathology. 3(2-3). 61–68. 1 indexed citations
8.
Morilla, Alison, David González de Castro, Ilaria Del Giudice, et al.. (2008). Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. Leukemia & lymphoma. 49(11). 2108–2115. 32 indexed citations
9.
Hockley, Sarah L., Stavroula Giannouli, Alison Morilla, et al.. (2007). Different IGH Rearrangement and Somatic Hypermutation Patterns in Hairy-Cell Leukemia, Hairy-Cell Leukemia Variant and Splenic Marginal Zone Lymphoma.. Blood. 110(11). 2082–2082. 2 indexed citations
10.
Giudice, Ilaria Del, Zadie Davis, Estella Matutes, et al.. (2006). IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL). Leukemia. 20(7). 1231–1237. 23 indexed citations
11.
Osuji, Nnenna, Estella Matutes, Alison Morilla, et al.. (2005). Prolonged treatment response in aggressive natural killer cell leukemia. Leukemia & lymphoma. 46(5). 757–763. 3 indexed citations
12.
Osuji, Nnenna, Ilaria Del Giudice, Estella Matutes, et al.. (2005). CD52 expression in T-cell large granular lymphocyte leukemia – Implications for treatment with alemtuzumab. Leukemia & lymphoma. 46(5). 723–727. 24 indexed citations
13.
Giudice, Ilaria Del, Alison Morilla, Nnenna Osuji, et al.. (2005). ζ‐Chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer. 104(10). 2124–2132. 52 indexed citations
14.
Morilla, Alison, David González, Ilaria Del Giudice, et al.. (2005). Combinations of ZAP-70, CD38 and IgVH Mutational Status as Predictors of Time to First Treatment in CLL.. Blood. 106(11). 711–711. 3 indexed citations
15.
Oscier, David, Sue Richards, Jenny Orchard, et al.. (2005). Prognostic Factors in the UK LRF CLL4 Trial.. Blood. 106(11). 2099–2099. 10 indexed citations
16.
Osuji, Nnenna, Ilaria Del Giudice, Estella Matutes, et al.. (2004). Intra-Lineage Phenotypic Switch in T-Cell Prolymphocytic Leukemia.. Blood. 104(11). 2005–2005. 1 indexed citations
17.
Catovsky, Daniel, Estella Matutes, Alison Morilla, et al.. (2004). Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women.. Blood. 104(11). 957–957. 6 indexed citations
18.
Delgado, Julio, et al.. (2003). Diagnostic Significance of CD20 and FMC7 Expression in B-Cell Disorders. American Journal of Clinical Pathology. 120(5). 754–759. 34 indexed citations
19.
Farahat, Nahla, Alison Morilla, K Owusu-Ankomah, et al.. (1998). Detection of minimal residual disease in B‐lineage acute lymphoblastic leukaemia by quantitative flow cytometry. British Journal of Haematology. 101(1). 158–164. 54 indexed citations
20.
Moreau, E, Estella Matutes, Roger A’Hern, et al.. (1997). Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b). American Journal of Clinical Pathology. 108(4). 378–382. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Lynn Breakdown of academic impact, for papers by J. Ellis Breakdown of academic impact, for papers by Alice Mohr Breakdown of academic impact, for papers by Sharron Glide Breakdown of academic impact, for papers by Silvia Zibellini Breakdown of academic impact, for papers by Emanuele Cencini Breakdown of academic impact, for papers by Lucile Baseggio Breakdown of academic impact, for papers by Fiona Bennett Breakdown of academic impact, for papers by Maurice Navarro Breakdown of academic impact, for papers by Michael Pearson
Rankless by CCL
2026